Develops robotic endoluminal surgery devices. Focuses on minimally invasive surgical solutions. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Debt is low and cash is strong; the finances stand solid.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Business Quality: Profit power and business quality trail similar companies in the sector.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
An investor who bought at the very peak is down 84% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $78.6M in the vault; even if every debt were paid off, $77.7M would remain.
Over the last 12 months, company executives reported 20 buys and 0 sells. Management buying with its own money is usually read as a good sign.
A loss of $13.1M against $0 in annual sales.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 15/100.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 20/100. For a turnaround signal, the stock first needs to close the gap with the market.
On our five-subject report card, MBOT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: MBOT is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (41/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the revenue breakdown.